Company Filing History:
Years Active: 2024
Title: Nina Miolane: Innovator in Neural Network Predictions
Introduction
Nina Miolane is a prominent inventor based in Santa Barbara, California. She has made significant contributions to the field of neural networks, particularly in predicting drug side effects. Her innovative approach combines advanced technology with pharmacological insights to enhance patient safety.
Latest Patents
Nina Miolane holds a patent for her invention titled "Multimodal cell complex neural networks for prediction of multiple drug side effects severity and frequency." This method involves training a multi-modal cell complex neural network (MCXN) on a comprehensive dataset. The MCXN incorporates nodes that represent drugs and proteins, along with pair-wise and k-wise relationships that illustrate interactions between these entities. The training dataset includes detailed information about various drugs and proteins, enabling the MCXN to predict the probabilities of potential side effects when administering a combination of at least three drugs concurrently. This invention aims to forecast both the frequency and severity of these side effects, thereby improving clinical outcomes.
Career Highlights
Throughout her career, Nina has worked with esteemed institutions such as Santa Clara University and the University of California. Her work has been instrumental in advancing the understanding of drug interactions and their implications for patient care.
Collaborations
Nina has collaborated with notable colleagues, including Mustafa Hajij and Ghada Alzamzmi. These partnerships have further enriched her research and contributed to the development of her innovative solutions.
Conclusion
Nina Miolane's work in neural network predictions represents a significant advancement in the field of pharmacology. Her patented technology has the potential to transform how healthcare professionals approach drug administration and patient safety.